CELATOR PHARMACEUTICALS INC's ticker is CPXX and the CUSIP is 15089R102. A total of 11 filers reported holding CELATOR PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $37,907,000 | +324.9% | 1,256,026 | +55.3% | 0.00% | +100.0% |
| Q1 2016 | $8,922,000 | +844.1% | 808,823 | +50.7% | 0.00% | – |
| Q4 2015 | $945,000 | -44.5% | 536,587 | -47.7% | 0.00% | – |
| Q3 2015 | $1,704,000 | +110.4% | 1,026,468 | +183.9% | 0.00% | – |
| Q2 2015 | $810,000 | -3.9% | 361,591 | +6.0% | 0.00% | – |
| Q1 2015 | $843,000 | +75.3% | 341,182 | +39.0% | 0.00% | – |
| Q4 2014 | $481,000 | -15.3% | 245,543 | +9.4% | 0.00% | – |
| Q3 2014 | $568,000 | -14.5% | 224,367 | 0.0% | 0.00% | – |
| Q2 2014 | $664,000 | +8.1% | 224,367 | +18.1% | 0.00% | – |
| Q1 2014 | $614,000 | – | 189,967 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,246,469 | $3,729,000 | 5.03% |
| TFS CAPITAL LLC | 22,443 | $37,000 | 0.00% |
| UBS Group AG | 500 | $1,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 67,015 | $111,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 25 | $0 | 0.00% |
| CITIGROUP INC | 135 | $0 | 0.00% |
| NORTHERN TRUST CORP | 20,724 | $35,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 34,795 | $58,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,200 | $4,000 | 0.00% |
| MORGAN STANLEY | 456 | $1,000 | 0.00% |